Cargando…
HbA(1c), Insulin Resistance, and β-Cell Function in Relation to Cognitive Function in Type 2 Diabetes: The CAROLINA Cognition Substudy
Autores principales: | Janssen, Jolien, van den Berg, Esther, Zinman, Bernard, Espeland, Mark A., Geijselaers, Stefan L.C., Mattheus, Michaela, Johansen, Odd Erik, Biessels, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905471/ https://www.ncbi.nlm.nih.gov/pubmed/30811335 http://dx.doi.org/10.2337/DC18-0914 |
Ejemplares similares
-
Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
por: Biessels, Geert Jan, et al.
Publicado: (2018) -
Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
por: Biessels, Geert Jan, et al.
Publicado: (2021) -
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA(®))
por: Marx, Nikolaus, et al.
Publicado: (2015) -
Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial
por: Espeland, Mark A., et al.
Publicado: (2020) -
Point-of-Care Measurements of HbA(1c): Simplicity Does Not Mean Laxity With Controls
por: Leca, Viviane, et al.
Publicado: (2012)